Skip to main content

Advertisement

Contact Young Suk Park

From: S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial

Contact corresponding author